Cancer is the second most common cause of death in the United States and according to the American Cancer Society Cancer Facts and Figures 2019, this year more than 1.7 million new cancer cases will be diagnosed and almost 607,000 Americans are expected to die of cancer.

https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html

Early detection of cancer increases the chances for successful treatment.

Biomarker testing identifies molecules or substances in the blood that can be produced as a biological response.

Cancer is a disease caused by uncontrolled division of abnormal cells and can start almost anywhere in the body.

Normal cells develop into specialized cells that mature and eventually die due to age or injury.

Cancer cells are less specialized than normal cells and unlike normal cells they continue to divide without stopping.

Methylscape is a common feature exhibited by most types of cancer and can be used as a cancer biomarker.

The IvyGene test measures cell-free DNA methylation ratios at specific gene targets to confirm the presence of cancer